Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20031252

Company安徽环球药业股份有限公司

Registration Date

February 10, 2021

Previous Approval Numbers

国药准字H20031252

Drug Information

Generic Name

盐酸昂丹司琼氯化钠注射液

Trade Name

恩复德

Brand Name

恩复德

Dosage Form

注射剂

Strength

100ml:昂丹司琼8mg与氯化钠0.9g

Drug Type

化学药品

Registration Date

February 10, 2021

Company Information

Applicant Company

Company Name安徽环球药业股份有限公司

Company Address

蚌埠市黄山大道3809号

Manufacturing Company

Company Name安徽环球药业股份有限公司

Company Address

蚌埠市华光大道1185号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy